TLDR: LMAX Group integrates RLUSD as core collateral across spot crypto, perpetual futures, and CFD trading platforms. Ripple provides $150 million financing toTLDR: LMAX Group integrates RLUSD as core collateral across spot crypto, perpetual futures, and CFD trading platforms. Ripple provides $150 million financing to

LMAX Group and Ripple Form Strategic Partnership to Integrate RLUSD Stablecoin for Institutional Trading

TLDR:

  • LMAX Group integrates RLUSD as core collateral across spot crypto, perpetual futures, and CFD trading platforms.
  • Ripple provides $150 million financing to support LMAX’s cross-asset growth and stablecoin adoption strategy.
  • Partnership combines LMAX Digital exchange with Ripple Prime to reduce market fragmentation for institutions.
  • RLUSD ranks among top five USD-backed stablecoins, offering 24/7 cross-asset market access for clients.

LMAX Group has formed a strategic alliance with Ripple to integrate RLUSD stablecoin across its institutional trading platform. 

The multi-year partnership includes $150 million in financing from Ripple. This collaboration aims to bridge traditional finance and digital asset markets through enhanced collateral options.

RLUSD Integration Expands Cross-Asset Trading Capabilities

The partnership enables LMAX Group to incorporate RLUSD as core collateral across its global marketplace infrastructure. 

Major financial institutions, including banks and brokers, will access improved margin efficiencies through this integration. 

LMAX announced the collaboration on social media, highlighting its commitment to accelerating institutional stablecoin adoption.

RLUSD will function as both collateral and settlement currency for spot cryptocurrency trading on the platform. 

Clients can utilize the stablecoin for margin funding across perpetual futures and CFD trading products. 

LMAX Custody will provide secure storage through segregated wallets, ensuring asset transferability between traditional and digital markets.

The integration supports 24/7 cross-asset market access through RLUSD fungibility. This feature addresses limitations currently present with fiat currency transactions. 

LMAX Kiosk will facilitate institutional on-ramps, allowing clients to trade multiple FX and digital products using RLUSD collateral.

David Mercer, Chief Executive Officer of LMAX Group, described the agreement as a major milestone for the company. 

“Partnering with a leader like Ripple is a milestone for LMAX, reflecting confidence and momentum in our cross-asset growth strategy,” Mercer stated. 

He added that fiat-backed stablecoins will drive convergence between traditional finance and digital assets with improved regulatory clarity.

Strategic Alliance Combines LMAX Exchange with Ripple Prime Services

The collaboration extends beyond stablecoin integration to include LMAX Digital exchange connection with Ripple Prime. 

This combination provides institutions with streamlined access to digital asset trading while reducing market fragmentation. 

Ripple Prime customers can now leverage LMAX Digital as a primary venue for price discovery and liquidity.

Jack McDonald, SVP of Stablecoins at Ripple, acknowledged institutions’ growing recognition of blockchain technology’s transformative potential. 

“Institutions are increasingly recognising the transformative potential of blockchain technology to modernise global financial market structure,” McDonald noted. 

He praised LMAX’s track record in delivering transparent and regulated infrastructure for institutional participants.

McDonald emphasized RLUSD’s market position and the partnership’s strategic value. He explained that RLUSD already ranks among the top five USD-backed stablecoins available. 

The collaboration will accelerate RLUSD utilization within one of the largest and most sophisticated trading environments globally.

Ripple’s financing commitment of $150 million supports LMAX Group’s long-term cross-asset growth strategy. 

This arrangement reflects both companies’ shared vision for building efficient, on-chain financial ecosystems. 

Ripple maintains over 75 regulatory licenses and registrations worldwide, providing compliant infrastructure for financial institutions. 

LMAX Group reported $8.2 trillion in institutional exchange volumes during 2025, building momentum through enhanced collateral flexibility.

The post LMAX Group and Ripple Form Strategic Partnership to Integrate RLUSD Stablecoin for Institutional Trading appeared first on Blockonomi.

Market Opportunity
FORM Logo
FORM Price(FORM)
$0.3663
$0.3663$0.3663
-2.99%
USD
FORM (FORM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23